02/02/2026
Global Observer published an in-depth interview with our Founder and CEO, Dr. Gordana Kalan Živčec, MD PhD, where she discusses Slovenia’s economic development, the country’s strong foundation in biotech and pharmaceutical education, and the motivation behind founding GaiaCell in 2024.
The interview covers GaiaCell’s focus on mesenchymal stem cells, extracellular vesicles (including exosomes), CAR-T therapies, and TILs, as well as the challenges of regulation, market access, and investment for advanced cell therapies in Europe.
It also outlines our vision of translating research into clinical practice and enabling broader access to personalized regenerative medicine.
👉 Read the full interview here: https://www.investslovenia-2026.com/interview/slovenias-regenerative-medicine-revolution/